259 results on '"Mittler, Robert S."'
Search Results
2. Supplementary Fig. from Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy
3. Regulation of T Cell-Dependent Humoral Immunity Through CD137 (4-1BB) Mediated Signals
4. Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation
5. Host CD25 +CD4 +Foxp3 + Regulatory T Cells Primed by anti-CD137 mAbs Inhibit Graft-versus-Host Disease
6. Lineage-specific T-cell reconstitution following in vivo CD4+ and CD8+ lymphocyte depletion in nonhuman primates
7. Correction: Corrigendum: Long-lived antigen-induced IgM plasma cells demonstrate somatic mutations and contribute to long-term protection
8. Polyspecific Self-Reactive Antibodies in Individuals Infected with Human Immunodeficiency Virus Facilitate T Cell Deletion and Inhibit Costimulatory Accessory Cell Function
9. Bone marrow–based homeostatic proliferation of mature T cells in nonhuman primates: implications for AIDS pathogenesis
10. T-Cell Receptor-CD4 Physical Association in a Murine T-Cell Hybridoma: Induction by Antigen Receptor Ligation
11. Multivalent 4-1BB binding aptamers costimulate [CD8.sup.+] T cells and inhibit tumor growth in mice
12. Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosus
13. Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent
14. Eradication of established tumors in mice by a combination antibody-based therapy
15. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer
16. REVERSE SIGNALING THROUGH CD137 LIGAND IN TUBULAR EPITHELIAL CELLS IS CRITICAL FOR RENAL ISCHEMIA-REPERFUSION INJURY: O-178
17. Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy
18. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor
19. Modulating Protective and Pathogenic CD4+ Subsets via CD137 in Type 1 Diabetes
20. CD137-mediated immunotherapy for allergic asthma
21. Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells
22. Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell–mediated protective immunity in Her-2/neu transgenic mice
23. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance
24. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine
25. Role of 4-1BB in Allograft Rejection Mediated by CD8+ T Cells
26. CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB × NZW F1 mice
27. CD137-Mediated T Cell Co-Stimulation Terminates Existing Autoimmune Disease in SLE-Prone NZB/NZW F1 Mice
28. 4-1BB co-stimulation enhances human CD8+ T cell priming by augmenting the proliferation and survival of effector CD8+ T cells
29. Anti-4-1BB Monoclonal Antibodies Abrogate T Cell-dependent Humoral Immune Responses In Vivo through the Induction of Helper T Cell Anergy
30. 4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
31. Suppressing the self in rheumatoid arthritis
32. Surface Expression of CD28 Single Chain Fv for Costimulation by Tumor Cells
33. The Two Membrane Proximal Domains of CD4 Interact with the T Cell Receptor
34. Long-lived antigen-induced IgM plasma cells demonstrate somatic mutations and contribute to long-term protection
35. Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans
36. The B10 Idd9.3 locus mediates accumulation of functionally superior CD137pos T regulatory cells in the NOD Type 1 diabetes model
37. Self-Antigen Prevents CD8 T Cell Effector Differentiation by CD134 and CD137 Dual Costimulation1
38. Cytokine-Mediated Disruption of Lymphocyte Trafficking, Hemopoiesis, and Induction of Lymphopenia, Anemia, and Thrombocytopenia in Anti-CD137-Treated Mice1
39. Targeting CD137 Enhances Vaccine-Elicited Anti–Respiratory Syncytial Virus CD8+ T Cell Responses in Aged Mice
40. Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice
41. TLR2 Signaling in Tubular Epithelial Cells Regulates NK Cell Recruitment in Kidney Ischemia–Reperfusion Injury
42. The B10 Idd9.3 Locus Mediates Accumulation of Functionally Superior CD137+ Regulatory T Cells in the Nonobese Diabetic Type 1 Diabetes Model
43. A Three-Dose Intramuscular Injection Schedule of Anthrax Vaccine Adsorbed Generates Sustained Humoral and Cellular Immune Responses to Protective Antigen and Provides Long-Term Protection against Inhalation Anthrax in Rhesus Macaques
44. Host CD25+CD4+Foxp3+ Regulatory T Cells Primed by anti-CD137 mAbs Inhibit Graft-versus-Host Disease
45. Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation
46. CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To Program Cytotoxic Th1 Differentiation
47. 4-1BB Signaling Synergizes with Programmed Death Ligand 1 Blockade To Augment CD8 T Cell Responses during Chronic Viral Infection
48. Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus
49. Dendritic Cells and Stat3 Are Essential for CD137-Induced CD8 T Cell Activation-Induced Cell Death
50. Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: Different effects on cellular and humoral immunity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.